Literature DB >> 31969449

Requirement for epithelial p38α in KRAS-driven lung tumor progression.

Jessica Vitos-Faleato1, Sebastián M Real1, Nuria Gutierrez-Prat1, Alberto Villanueva2, Elisabet Llonch1, Matthias Drosten3, Mariano Barbacid3, Angel R Nebreda4,5.   

Abstract

Malignant transformation entails important changes in the control of cell proliferation through the rewiring of selected signaling pathways. Cancer cells then become very dependent on the proper function of those pathways, and their inhibition offers therapeutic opportunities. Here we identify the stress kinase p38α as a nononcogenic signaling molecule that enables the progression of KrasG12V-driven lung cancer. We demonstrate in vivo that, despite acting as a tumor suppressor in healthy alveolar progenitor cells, p38α contributes to the proliferation and malignization of lung cancer epithelial cells. We show that high expression levels of p38α correlate with poor survival in lung adenocarcinoma patients, and that genetic or chemical inhibition of p38α halts tumor growth in lung cancer mouse models. Moreover, we reveal a lung cancer epithelial cell-autonomous function for p38α promoting the expression of TIMP-1, which in turn stimulates cell proliferation in an autocrine manner. Altogether, our results suggest that epithelial p38α promotes KrasG12V-driven lung cancer progression via maintenance of cellular self-growth stimulatory signals.

Entities:  

Keywords:  KRAS; TIMP-1; lung adenocarcinoma; nononcogene addiction; p38α

Mesh:

Substances:

Year:  2020        PMID: 31969449      PMCID: PMC7007552          DOI: 10.1073/pnas.1921404117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  55 in total

Review 1.  Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation.

Authors:  Patrick Viatour; Marie-Paule Merville; Vincent Bours; Alain Chariot
Journal:  Trends Biochem Sci       Date:  2005-01       Impact factor: 13.807

2.  Proline isomerisation as a novel regulatory mechanism for p38MAPK activation and functions.

Authors:  A Brichkina; N Tm Nguyen; R Baskar; S Wee; J Gunaratne; R C Robinson; D V Bulavin
Journal:  Cell Death Differ       Date:  2016-05-27       Impact factor: 15.828

3.  Role of p38 MAPK and NF-kB for chemokine release in coculture of human eosinophils and bronchial epithelial cells.

Authors:  C K Wong; C B Wang; W K Ip; Y P Tian; C W K Lam
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

4.  Selective p38 activation in human non-small cell lung cancer.

Authors:  Alissa K Greenberg; Sharmila Basu; Jing Hu; Ting-an Yie; Kam Meng Tchou-Wong; William N Rom; Theodore C Lee
Journal:  Am J Respir Cell Mol Biol       Date:  2002-05       Impact factor: 6.914

5.  Sunlight UV-induced skin cancer relies upon activation of the p38α signaling pathway.

Authors:  Kangdong Liu; Donghoon Yu; Yong-Yeon Cho; Ann M Bode; Weiya Ma; Ke Yao; Shengqing Li; Jixia Li; G Tim Bowden; Ziming Dong; Zigang Dong
Journal:  Cancer Res       Date:  2013-02-04       Impact factor: 12.701

6.  A role for p38 MAPK in head and neck cancer cell growth and tumor-induced angiogenesis and lymphangiogenesis.

Authors:  Kantima Leelahavanichkul; Panomwat Amornphimoltham; Alfredo A Molinolo; John R Basile; Sittichai Koontongkaew; J Silvio Gutkind
Journal:  Mol Oncol       Date:  2013-10-12       Impact factor: 6.603

7.  Upregulation of the tissue inhibitor of metalloproteinase-1 protein is associated with progression of human non-small-cell lung cancer.

Authors:  Ibrahim S Aljada; Nithya Ramnath; Kathleen Donohue; Shashi Harvey; John J Brooks; Sam M Wiseman; Thaer Khoury; Gregory Loewen; Harry K Slocum; Timothy M Anderson; Gerold Bepler; Dongfeng Tan
Journal:  J Clin Oncol       Date:  2004-07-12       Impact factor: 44.544

8.  Mitogen-activated protein kinase activation in lung adenocarcinoma: a comparative study between ever smokers and never smokers.

Authors:  Giannis Mountzios; David Planchard; Benjamin Besse; Pierre Validire; Philippe Girard; Christine Devisme; Meletios-Athanasios Dimopoulos; Jean-Charles Soria; Pierre Fouret
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

9.  p38alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway.

Authors:  Lijian Hui; Latifa Bakiri; Andreas Mairhorfer; Norbert Schweifer; Christian Haslinger; Lukas Kenner; Vukoslav Komnenovic; Harald Scheuch; Hartmut Beug; Erwin F Wagner
Journal:  Nat Genet       Date:  2007-04-29       Impact factor: 38.330

10.  Myeloid p38α signaling promotes intestinal IGF-1 production and inflammation-associated tumorigenesis.

Authors:  Catrin Youssif; Monica Cubillos-Rojas; Mònica Comalada; Elisabeth Llonch; Cristian Perna; Nabil Djouder; Angel R Nebreda
Journal:  EMBO Mol Med       Date:  2018-07       Impact factor: 12.137

View more
  9 in total

1.  SEMA3C Supports Pancreatic Cancer Progression by Regulating the Autophagy Process and Tumor Immune Microenvironment.

Authors:  Dalin Zhang; Aaron Lindstrom; Edward J Kim; Chang-Il Hwang; Madison Lee Hall; Tzu-Yin Lin; Yuanpei Li
Journal:  Front Oncol       Date:  2022-06-16       Impact factor: 5.738

2.  Algorithmic assessment of cellular senescence in experimental and clinical specimens.

Authors:  J Kohli; B Wang; S M Brandenburg; N Basisty; K Evangelou; M Varela-Eirin; J Campisi; B Schilling; V Gorgoulis; M Demaria
Journal:  Nat Protoc       Date:  2021-04-28       Impact factor: 13.491

Review 3.  Diversity and versatility of p38 kinase signalling in health and disease.

Authors:  Begoña Canovas; Angel R Nebreda
Journal:  Nat Rev Mol Cell Biol       Date:  2021-01-27       Impact factor: 113.915

Review 4.  CDK4/6 and MAPK-Crosstalk as Opportunity for Cancer Treatment.

Authors:  Lisa Scheiblecker; Karoline Kollmann; Veronika Sexl
Journal:  Pharmaceuticals (Basel)       Date:  2020-11-24

Review 5.  Functional Roles of JNK and p38 MAPK Signaling in Nasopharyngeal Carcinoma.

Authors:  Lesley Jia Wei Pua; Chun-Wai Mai; Felicia Fei-Lei Chung; Alan Soo-Beng Khoo; Chee-Onn Leong; Wei-Meng Lim; Ling-Wei Hii
Journal:  Int J Mol Sci       Date:  2022-01-20       Impact factor: 5.923

6.  Lung Volume Calculation in Preclinical MicroCT: A Fast Geometrical Approach.

Authors:  Juan Antonio Camara; Anna Pujol; Juan Jose Jimenez; Jaime Donate; Marina Ferrer; Greetje Vande Velde
Journal:  J Imaging       Date:  2022-07-22

7.  Upregulation of Chemoresistance by Mg2+ Deficiency through Elevation of ATP Binding Cassette Subfamily B Member 1 Expression in Human Lung Adenocarcinoma A549 Cells.

Authors:  Saki Onuma; Aya Manabe; Yuta Yoshino; Toshiyuki Matsunaga; Tomohiro Asai; Akira Ikari
Journal:  Cells       Date:  2021-05-12       Impact factor: 6.600

Review 8.  p38β and Cancer: The Beginning of the Road.

Authors:  Olga Roche; Diego M Fernández-Aroca; Elena Arconada-Luque; Natalia García-Flores; Liliana F Mellor; María José Ruiz-Hidalgo; Ricardo Sánchez-Prieto
Journal:  Int J Mol Sci       Date:  2020-10-12       Impact factor: 5.923

9.  JunD, not c-Jun, is the AP-1 transcription factor required for Ras-induced lung cancer.

Authors:  E Josue Ruiz; Linxiang Lan; Markus Elmar Diefenbacher; Eva Madi Riising; Clive Da Costa; Atanu Chakraborty; Joerg D Hoeck; Bradley Spencer-Dene; Gavin Kelly; Jean-Pierre David; Emma Nye; Julian Downward; Axel Behrens
Journal:  JCI Insight       Date:  2021-07-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.